SIM
ABUS icon

Sonora Investment Management’s Arbutus Biopharma ABUS Stock Holding History

Sonora Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20
Closed – – 1249
2018
Q3 		$0 Hold
20
– – ﹤0.01% 1207
2018
Q2 		$0 Hold
20
– – ﹤0.01% 1170
2018
Q1 		$100 Hold
20
– – ﹤0.01% 1166
2017
Q4 		$101 Hold
20
– – ﹤0.01% 1175
2017
Q3 		$124 Hold
20
– – ﹤0.01% 1133
2017
Q2 		$72 Hold
20
– – ﹤0.01% 972
2017
Q1 		$65 Hold
20
– – ﹤0.01% 925
2016
Q4 		$49 Hold
20
– – ﹤0.01% 841
2016
Q3 		$69 Hold
20
– – ﹤0.01% 824
2016
Q2 		$70 Hold
20
– – ﹤0.01% 848
2016
Q1 		$106 Hold
20
– – ﹤0.01% 937
2015
Q4 		$0 Hold
20
– – ﹤0.01% 783
2015
Q3 		$0 Buy
+20
New +$177 ﹤0.01% 1080

Other funds holding ABUS

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sonora Investment Management's ABUS Position: Q4 2018 in Review

Sonora Investment Management sold out of Arbutus Biopharma (ABUS) in Q4 2018, closing a stake of 20 shares.

Sonora Investment Management first reported a position in ABUS in Q3 2015 and held it in 13 quarters. The position peaked at $124 in Q3 2017. 71 funds tracked by Wall St. Rank hold ABUS as of Q4 2018.

  • Sonora Investment Management reported no remaining Arbutus Biopharma position as of Q4 2018 after selling out during the quarter.
  • Sonora Investment Management sold 20 Arbutus Biopharma shares in Q4 2018.
  • Sonora Investment Management first reported a position in Arbutus Biopharma in Q3 2015 and held it in 13 quarters.
  • Sonora Investment Management's Arbutus Biopharma position peaked at $124 in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2018.

Based on Sonora Investment Management's 13F filing for Q4 2018, filed 25 Jan 2019.